Axelia Oncology
About:
Axelia Oncology is a biopharmaceutical company provides transformation of treatment of insensitive cancers.
Website: https://axeliaoncology.com/
Top Investors: Brandon Capital, Uniseed
Description:
Axelia Oncology is a biopharmaceutical company aiming to transform the treatment of checkpoint-insensitive cancers by the activation of TLR2/6 engagement of the innate immune response.
Total Funding Amount:
11.7M AUD
Headquarters Location:
Melbourne, Victoria, Australia
Founded Date:
2014-01-01
Contact Email:
ceo(AT)axeliaoncology.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2020-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai